Adaptimmune Therapeutics (ADAP)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.58

-0.38%

After-hours Dec 13, 2024, 07:03 PM EST

Adaptimmune Therapeutics Forcast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for ADAP stock have an median target of 3.15, with a low estimate of 3 and a high estimate of 3.5. The median target predicts an increase of 433.90% from the current stock price of 0.59.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3	$3.22	$3.15	$3.5
Change	408.47%	445.76%	433.90%	493.22%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Adap... Unlock content with Pro Subscription

Updated Nov 19, 2024

Rating	May 24	Jul 24	Aug 24	Nov 24
Strong Buy	0	0	0	0
Buy	2	1	2	4
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	2	1	2	4

Financial Forecast this Year

Revenue This Year

150.77M

from 60.51M

149.1%

from 60.51M

Revenue Next Year

45.01M

from 150.77M

-70.1%

from 150.77M

EPS This Year

-0.05

from -0.57

91.2%

from -0.57

EPS Next Year

-0.55

from -0.05

-1K%

from -0.05